DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers free radicals

Cancer Research

Volumn 66, Issue 24, 2006, Pages 11938-11945

  Alexandrov, Kroum ^a,b   Rojas, Margarita ^c   Rolando, Christian ^c  

^a UNIV LILLE   (France)

^b CNRS   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE; BENZO[A]PYRENE; CATALASE; CYTOCHROME P450; FREE RADICAL; REACTIVE OXYGEN METABOLITE; ROSMARINUS OFFICINALIS EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENIC ACTIVITY; CATALYSIS; CELL FREE SYSTEM; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DRUG BINDING; DRUG INHIBITION; HUMAN; HUMAN CELL; LUNG TUMOR; PRIORITY JOURNAL; STEREOCHEMISTRY;

BENZO(A)PYRENE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA; DNA DAMAGE; DNA, NEOPLASM; FEMALE; FILTRATION; FREE RADICALS; HUMANS; PLANT EXTRACTS; POWDERS; ROSMARINUS; SMOKE;

EID: 33846240854     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3277     Document Type: Article

References (56)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
2. Van Duuren BL. Polynuclear aromatic hydrocarbons in cigarette-smoke condensate II. J Natl Cancer Inst 1958;21:623-30.
3. Van Duuren BL. Identification of some polynuclear aromatic hydrocarbons in cigarette-smoke condensate. J Natl Cancer Inst 1958;21:1-16.
4. Wynder EL, Hoffmann D. Tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons. Cancer 1959;12:1079-86.
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data. IARC Monogr Eval Carcinog Risk Chem Hum 1983;32:1-453.
6. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
7. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210.
8. Osborne MR, Beland FA, Harvey RG, Brookes P. The reaction of (+/-)-7a,8b-dihydroxy-9b,10b-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene with DNA. Int J Cancer 1976;18:362-8.
9. Boysen G, Hecht SS. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat Res 2003;543:17-30.
10. Rojas M, Marie B, Vignaud JM, et al. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma. Cancer Lett (Amsterdam, Neth) 2004;207:157-63.
11. Gelboin HV. Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980;60:1107-66.
12. Levin W, Wood A, Chang R, et al. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. Drug Metab Rev 1982;13:555-80.
13. Borgen A, Darvey H, Castagnoli N, Crocker TT, Rasmussen RE, Wang IY. Metabolic conversion of benzo[a]pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. J Med Chem 1973;16:502-6.
14. Huberman E, Sachs L, Yang SK, Gelboin HV. Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc Natl Acad Sci U S A 1976;73:607-11.
15. Newbold RF, Brookes P. Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cells. Nature (London, UK) 1976;261:52-4.
16. Slaga TJ, Viaje A, Berry DL, Bracken W, Buty SG, Scribner JD. Skin tumor initiating ability of benzo(a)pyrene 4,5- 7,8- and 7,8-diol-9,10-epoxides and 7,8-diol. Cancer Lett (Shannon, Irel) 1976;2:115-21.
17. Yang SK, McCourt DW, Leutz JC, Gelboin HV. Benzo[a]pyrene diol epoxides: mechanism of enzymic formation and optically active intermediates. Science (Washington DC) 1977;196:1199-201.
18. Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 2003;43:149-73.
19. Borm PJ, Knaapen AM, Schins RP, Godschalk RW, Schooten FJ. Neutrophils amplify the formation of DNA adducts by benzo[a]pyrene in lung target cells. Environ Health Perspect 1997;105 Suppl 5:1089-93.
20. Marnett LJ. Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates. Environ Health Perspect 1990;88:5-12.
21. Pruess-Schwartz D, Nimesheim A, Marnett LJ. Peroxyl radical- and cytochrome P-450-dependent metabolic activation of (+)-7,8-dihydroxy-7,8- dihydrobenzo(a)pyrene in mouse skin in vitro and in vivo. Cancer Res 1989;49:1732-7.
22. Trush MA, Kensler TW. Role of free radicals in carcinogen activation. In: Sies H. (ed). Oxidative stress: oxidants and antioxidant. Academic Press. New York, 1991;227-318.
23. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med 1991;10:201-9.
24. Wiese FW, Thompson PA, Kadlubar FF. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 2001;22:5-10.
25. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997;105 1997:105875-82.
26. Pryor WA, Hales BJ, Premovic PI, Church DF. The radicals in cigarette tar: their nature and suggested physiological implications. Science 1983;220:425-7.
27. Pryor WA, Stone K, Zang L-Y, Bermudez E. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 1998;11:441-8.
28. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;227:375-81.
29. Kozumbo WJ, Trush MA, Kensler TW. Are free radicals involved in tumor promotion? Chem Biol Interact 1985;54:199-207.
30. Nakayama T, Kaneko M, Kodama M, Nagata C. Cigarette smoke induces DNA single-strand breaks in human cells. Nature (London, UK) 1985;314:462-4.
31. Nakayama T, Kodama M, Nagata C. Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 1984;75:95-8.
32. Emami I, inventor; Francaise d'Aromes et Parfums, assignee. Utilisation de composés polyphénoliques ou de leur dérivés comme capteurs de radicaux libres dans les filtres de cigarette [Use of polyphenol compounds or their derivatives as scavengers of free radicals in cigarette filters]. FR patent 2772561 1997 Dec 24.
33. Masselot D. Identification et quantification des radicaux libres par spectrométrie de masse. Application à l'étude et à la dimminution des radicaux libres contenus dans les fumées de cigarette [Identification and quantitation of free radicals by mass spectrometry. Application to the study and to the decrease of free radicals contained in cigarette smoke] [dissertation]: Université des Sciences et Technologies de Lille (Lille 1); 2004.
34. Kuljukka-Rabb T, Peltonen K, Isotalo S, Mikkonen S, Rantanen L, Savela K. Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methylchrysene in a human mammary carcinoma cell line (MCF-7). Mutagenesis 2001;16:353-8.
35. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
36. Alexandrov K, Rojas M, Geneste O, et al. An improved fluorometric assay for dosimetry of benzo[a]pyrenediol epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 1992;52:6248-53.
37. Rojas M, Alexandrov K, van Schooten FJ, Hillebrand M, Kriek E, Bartsch H. Validation of a new fluorometric assay for benzo[a]pyrenediol epoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA. Carcinogenesis 1994;15:557-60.
38. Rojas M, Godschalk R, Alexandrov K, et al. Myeloperoxidase-463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. Carcinogenesis 2001;22:1015-8.
39. Jansen EHJM, van den Berg RH, Kroese ED. Liquid chromatographic analysis and stability of benzo[a]pyrenetetrols in blood protein adducts in rats after exposure to benzo[a]pyrene. Anal Chim Acta 1994;290:86-93.
40. Loechler EL. The role of adduct site-specific mutagenesis is understanding how carcinogen-DNA adducts cause mutations: perspective, prospects, and problems. Carcinogenesis 1996;17:895-902.
41. Rodgman A, Smith CJ, Perfetti TA. The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 2000;19:573-95.
42. Shinagawa K, Tokimoto T, Shirane K. Spin trapping of nitric oxide in aqueous solutions of cigarette smoke. Biochem Biophys Res Commun 1998;253:99-103.
43. Barouki R, Morel Y. Repression of cytochrome P450 IA1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 2001;61:511-6.
44. Bassi AM, Ledda S, Penco S, et al. Changes of CYP1A1, GST, and ALDH3 enzymes in hepatoma cell lines undergoing enhanced lipid peroxidation. Free Radic Biol Med 2000;29:1186-96.
45. Spink DC, Spink BC, Cao JQ, et al. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 1998;19:291-8.
46. Hainaut P, Pfeifer GP. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001;22:367-74.
47. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage, and p53 mutations in smoking-associated cancers. Oncogene 2002;21:7435-51.
48. Tokuda H, Ohigashi H, Koshimizu K, Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol 13-acetate. Cancer Lett (Shannon, Irel) 1986;33:279-85.
49. Singletary KW, Nelshoppen JM. Inhibition of 7,12-dimethylbenz[a] anthracene (DMBA)-induced mammary tumorigenesis and of in vivo formation of mammary DMBA-DNA adducts by rosemary extract. Cancer Lett (Shannon, Irel) 1991;60:169-75.
50. Huang MT, Ho CT, Wang ZY, et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994;54:701-8.
51. Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthraacene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett (Shannon, Irel) 1996;104:43-8.
52. Debersac P, Heydel JM, Amiot MJ, et al. Induction of cytochrome P450 and/or detoxication enzymes by various extracts of rosemary: description of specific patterns. Food Chem Toxicol 2001;39:907-18.
53. Debersac P, Vernevaut MF, Amiot MJ, Suschetet M, Siess MH. Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver. Food Chem Toxicol 2001;39:109-17.
54. Offord EA, Mace K, Avanti O, Pfeifer AMA. Mechanisms involved in the chemoprotective effects of rosemary extract studied in human liver and bronchial cells. Cancer Lett (Shannon, Irel) 1997;114:275-81.
55. Chan MM-Y, Ho C-T, Huang H-I. Effects of three dietary phytochemicals from tea, rosemary, and turmeric on inflammation-induced nitrite production. Cancer Lett (Shannon, Irel) 1995;96:23-9.
56. Offord EA, Mace K, Ruffeux C, Malnoe A, Pfeifer AMA. Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 1995;16:2057-62.